Literature DB >> 2279616

Calpains (intracellular calcium-activated cysteine proteinases): structure-activity relationships and involvement in normal and abnormal cellular metabolism.

P Johnson1.   

Abstract

1. Calpains (calcium-activated cysteine proteinases) have evolved by gene fusion events involving calmodulin-like genes, cysteine proteinase genes and other sequences of unknown origin. 2. The enzymes are composed of two non-identical subunits, each of which contains functional calcium-binding sequences. 3. Calpains are inhibited by the endogenous protein inhibitor, calpastatin and some calmodulin antagonists are also inhibitors of calpain. A number of synthetic proteinase inhibitors also inhibit calpains. 4. Calpains can be activated by phospholipids, an endogenous protein activator and some amino acid derivatives. 5. Various protein substrates for calpains have been recognized in vitro, but the identity of in situ substrates remains unclear. 6. Proposals have been made for calpain function, including involvement in signal transduction, platelet activation, cell fusion, mitosis and cytoskeleton and contractile protein turnover. 7. Calpain and calpastatin expression is altered in a number of abnormal states including muscular dystrophy, muscle denervation and tenotomy, hypertension and platelet abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2279616     DOI: 10.1016/0020-711x(90)90284-a

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  9 in total

Review 1.  Regulation by proteolysis: energy-dependent proteases and their targets.

Authors:  S Gottesman; M R Maurizi
Journal:  Microbiol Rev       Date:  1992-12

2.  Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients.

Authors:  O Mansoor; B Beaufrere; Y Boirie; C Ralliere; D Taillandier; E Aurousseau; P Schoeffler; M Arnal; D Attaix
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

3.  Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging.

Authors:  D Dardevet; C Sornet; D Taillandier; I Savary; D Attaix; J Grizard
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

4.  Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle.

Authors:  D Taillandier; E Aurousseau; D Meynial-Denis; D Bechet; M Ferrara; P Cottin; A Ducastaing; X Bigard; C Y Guezennec; H P Schmid
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

5.  Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.

Authors:  D H Pliura; B J Bonaventura; R A Smith; P J Coles; A Krantz
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

6.  Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.

Authors:  T Tsujinaka; J Fujita; C Ebisui; M Yano; E Kominami; K Suzuki; K Tanaka; A Katsume; Y Ohsugi; H Shiozaki; M Monden
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

7.  CalpA, a Drosophila calpain homolog specifically expressed in a small set of nerve, midgut, and blood cells.

Authors:  U Theopold; M Pintér; S Daffre; Y Tryselius; P Friedrich; D R Nässel; D Hultmark
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

9.  Effects of mechanical force on cytoskeleton structure and calpain-induced apoptosis in rat dorsal root ganglion neurons in vitro.

Authors:  Zhengxu Ye; Yuqing Wang; Xin Quan; Jing Li; Xueyu Hu; Jinghui Huang; Zhuojing Luo
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.